대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)

  • 제29권4호
  • /
  • Pages.97-107
  • /
  • 2015
  • /
  • 1226-8038(pISSN)
  • /
  • 2287-9463(eISSN)
대한한방소아과학회 (The Association of Korean Oriental Pediatrics)
권호 표지
DOI QR코드

DOI QR Code

하태독법 중 황련감초법이 DNFB로 유발된 NC/Nga 생쥐의 아토피 피부염에 미치는 영향

The Effects of Hataedock on 2,4-dinitrofluorobenzene Induced Atopic Dermatitis Like Skin Lesion in NC/Nga Mice

  • 차호열 (부산대학교한방병원 한방소아과) ;
  • 안상현 (부산대학교 한의과학연구소) ;
  • 정아람 (부산대학교한방병원 한방소아과) ;
  • 천진홍 (부산대학교한방병원 한방소아과) ;
  • 박선영 (세명대학교 한의과대학 생리학교실) ;
  • 김기봉 (부산대학교한방병원 한방소아과)
  • Cha, Ho Yeol (Department of Pediatrics of Korean Medicine, Pusan National University Hospital) ;
  • Ahn, Sang Hyun (Research Institute for Korean Medicine, Pusan National University) ;
  • Jeong, A Ram (Department of Pediatrics of Korean Medicine, Pusan National University Hospital) ;
  • Cheon, Jin Hong (Department of Pediatrics of Korean Medicine, Pusan National University Hospital) ;
  • Park, Sun Young (Department of physiology, college of Korean Medicine, Semyung University) ;
  • Kim, Ki Bong (Department of Pediatrics of Korean Medicine, Pusan National University Hospital)
  • 투고 : 2015.10.22
  • 심사 : 2015.11.11
  • 발행 : 2015.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives Hataedock is the treatment that dispels toxic heat and meconium gathered at the fetus for the new born baby by orally administered herbal extracts. The purpose of this study was to evaluate whether Hataedock alleviate inflammatory skin damages in AD-induced NC/Nga mice through regulating of skin barrier maintain and Th2 differentiation. Methods We established an AD model in the 3-week-old NC/Nga mice through the repeated application of DNFB (dinitrochlorobenzene) on days 28, 35, 42 after Hataedock treatment which was orally administered. We identified the changes of skin barrier and Th2 differentiation through the histological and immunohistochemical changes of protein kinase C (PKC), interleukin (IL)-4, degranulated mast cell, Substance P and MMP-9. Results Our results suggested that Hataedock treatment significantly down-regulated levels of PKC by 82% (p < 0.001), as well as IL-4 by 56% (p < 0.001). Hataedock also suppressed mast cell infiltration, ear edema formation. and Substance P in the tissue of NC/Nga mice were decreased by 57% (p < 0.001), and MMP-9 by 55% (p < 0.001). Conclusions These results suggest that Hataedock alleviates AD through the down-regulation of PKC and Th2 cytokines, which are involved in the initial steps of AD development. Hataedock have potential application for the treatment of AD.

키워드

참고문헌

  1. Korean Dermatological Association Textbook Compilation Committee. Dermatology, 5th. Seoul: Ryo Moon Gak. 2008:170-1.
  2. Blume-Peytavi U, Metz M. Atopic dermatitis in children: management of pruritus. J Eur Acad Dermatol Venereol. 2012;26:2-8.
  3. Addor FA, Takaoka R, Rivitti EA, Aoki V. Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity. Int J Dermatol 2012;51:672-6. https://doi.org/10.1111/j.1365-4632.2011.05176.x
  4. Kabashima K. New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity. J Invest Dermatol. 2013;70:3-11.
  5. Leung DY. Atopy dermatitis: new insight and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000;105:860-7. https://doi.org/10.1067/mai.2000.106484
  6. Beltrani VS. The role of house dust mites and other aeroallergens in atopic dermatitis. Clin Dermatol. 2003;21(3):177-82. https://doi.org/10.1016/S0738-081X(02)00366-8
  7. Jiangyu R. Practical TCM Pediatrics. Shanghai: Shanghai Science and Technology Press. 2005.
  8. Kang MY, Jang GT, Kim JH. A study on fetal toxicosis removal therapy. J Pediatr Korean Med. 2003;17(1):9-51.
  9. Heo J. DongUiBoGam. 2nd ed. Seoul: NamSanDang. 2004.
  10. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483-94. https://doi.org/10.1056/NEJMra074081
  11. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/ RACTALL Consensus Report. J Allergy Clin Immunol. 2006;118(1):152-69. https://doi.org/10.1016/j.jaci.2006.03.045
  12. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8):1892-908. https://doi.org/10.1038/jid.2009.133
  13. Ye YM, Kim BE, Shin YS, Park HS, Leung DYM. Overexpression of epidermal filaggrin in patients with chronic idiopathic urticaria correlates with urticaria severity. J Allergy Clin Immunol. 2013;131(2):AB56.
  14. Sandstrom MH, Faergemann J. Prognosis and prognostic factors in adult patient with atopic dermatitis : a long-term follow-up qeustionnaire study. Br J Dermatol. 2004;150:103-10. https://doi.org/10.1111/j.1365-2133.2004.05711.x
  15. Dupuy P. Does atopic dermatitis result from cytokine dysregulation?. J invest Dermatol. 1994;92:44-7.
  16. Kim JW. Allergy and immunological perspective in atopic dermatitis. J Korean Dermatol Assoc. 2003;41(6): 687-9.
  17. Ahn PS, Bang HD, Jung JH, Kim GH, Park KC, Yoon JI. Effect of recombinant interferon gamma on the treatment of atopic dermatitis. J Immunol. 1996;16(3):291-8. https://doi.org/10.1007/BF01541395
  18. Sung HC, Lee WJ, Lee SJ, Kim DW. A study on the relationship of allergy-related labaratory findings with the clinical severity of atopic dermatitis. J Korean Dermatol Assoc. 2006;44(9):1051-7.
  19. Sidbury R, Hanifin JM. Old, new, and emerging therapies for atopic dermatitis. Dermatolo Clin. 2000;18(1):1-11.
  20. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13(4):136-42. https://doi.org/10.1016/0167-5699(92)90111-J
  21. Kim SH, Kim S, Lee SH, Park HW, Chang YS, Min KU, Cho SH. The effects of PG102, a water-soluble extract from actinidia arguta, on serum total IgE levels:a double-blind, randomized, placebo-controlled exploratory clinical study. Eur J Nutr. 2011;50(7):523-9. https://doi.org/10.1007/s00394-010-0159-y
  22. Kim D, Kim SH, Park EJ, Kang CY, Cho SH, Kim S. Anti-allergic effects of PG102, a water-soluble extract prepared from actinidia arguta, in a murine ovalbumin-induced asthma model. Clin Exp Allergy. 2009;39(2):280-9. https://doi.org/10.1111/j.1365-2222.2008.03124.x
  23. Jo JJ. Gup Yu Bang. Seoul: Yeo kang publishing company. 1998:44.
  24. Jeong JM. A study regarding current usage of Ha-Taedok method in korean pediatrician. J Pediatr Korean Med. 2014;28(2):88-102. https://doi.org/10.7778/jpkm.2014.28.2.088
  25. Jeong JM. A study regarding current usage of Ha-Taedok method in postpartum mothers. J Pediatr Korean Med. 2014;28(4):157-65. https://doi.org/10.7778/jpkm.2014.28.4.0157
  26. Yu JG, Yuan RJ. Rhubarb and licorice tang in use in neonatal diseases. Henan Medical Information. 2008; 6(8):46-7.
  27. Korea Centers for Disease Control and Prevention. Childhood asthma and allergic diseases cohort study, 4th study 2012. Retrieved on April 24, 2013 from http: / /www.cdc.go.kr/CDC/ info/CdcKrInfo0 201 jsp?menuIds=HOME001-MNU1155-MNU1083- MNU1375-MNU0025&cid=21510.
  28. Korean Medical Pharmacology Text publication committee. Korean medical pharmacology. Seoul: Shinil Books. 2010:116-249.
  29. Moon A, Kim SH. Effect of Glycyrrhiza glabra roots and glycyrrhizin on the glucuronidation in rats. Planta Med. 1997;63:115-9. https://doi.org/10.1055/s-2006-957625
  30. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136(7):2348-57.
  31. Miraglia del Giudice M, Decimo F, Leonardi S, Maioello N, Amelio R, Capasso A, Capristo C, Capristo AF. Immune dysregulation in atopic dermatitis. Allergy Asthma Proc. 2006;27(6):451-5.
  32. Antunez C, Torres MJ, Mayorga C, Corzo JL, Jurado A, Santamaria-Babi LF, Vera A, Blanca M. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma. Pediatr Allergy Immunol. 2006;17(3):166-74. https://doi.org/10.1111/j.1399-3038.2006.00390.x
  33. Lee HH. Atopic Dermatitis and Epidermal Barrier. Allergy Asthma & Respiratory Disease. 2009;19(2):95-105.
  34. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol. 2001;166(6):3873-81. https://doi.org/10.4049/jimmunol.166.6.3873
  35. Chen L, Grabowski KA, Xin JP, Coleman J, Huang Z, Espiritu B, Alkan S, Xie HB, Zhu Y, White FA, Clancy J Jr, Huang H. IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils. J Immunol. 2004;172(4):2059-66. https://doi.org/10.4049/jimmunol.172.4.2059
  36. Marsland BJ, Soos TJ, Späth G, Littman DR, Kopf M. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J Exp Med. 2004;200(2):181-9. https://doi.org/10.1084/jem.20032229
  37. Amin K. The role of mast cells in allergic inflammation. Respir Med. 2012;106(1):9-14. https://doi.org/10.1016/j.rmed.2011.09.007
  38. Park SW, Yan YP, Satriotomo I, Vemuganti R, Dempsey RJ. Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J Neurosurg. 2007;107(3):593-9. https://doi.org/10.3171/JNS-07/09/0593
  39. Donkin JJ, Turner RJ, Hassan I, Vink R. Substance P in traumatic brain injury. Prog Brain Res. 2007;161:97-109. https://doi.org/10.1016/S0079-6123(06)61007-8
  40. Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids. 2006;31(3): 251-72. https://doi.org/10.1007/s00726-006-0335-9
  41. Yamaoka J, Kawana S. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice. J Dermatol Sci. 2007;48(2):123-32. https://doi.org/10.1016/j.jdermsci.2007.06.007
  42. Hon KL, Lam MC, Wong KY, Leung TF, Ng PC. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Br J Dermatol. 2007;157(5):922-5. https://doi.org/10.1111/j.1365-2133.2007.08149.x
  43. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol. 2002;147(1):71-9. https://doi.org/10.1046/j.1365-2133.2002.04803.x
  44. Woessner JF Jr. MMPs and TIMPs-an historical perspective. Mol Biotechnol. 2002;22(1):33-49. https://doi.org/10.1385/MB:22:1:033
  45. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases; role in arthritis. Front Biosci. 2006;1:529 -43.
  46. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblast of rheumatoid arthritis. J Biol Chem. 2000;275(1):444-50. https://doi.org/10.1074/jbc.275.1.444

피인용 문헌

  1. Hataedock Treatment Has Preventive Therapeutic Effects in Atopic Dermatitis-Induced NC/Nga Mice under High-Fat Diet Conditions vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/1739760
  2. 아토피 피부염의 한의학적 치료에 대한 연구 동향 -대한한방소아과학회지를 중심으로- vol.31, pp.1, 2015, https://doi.org/10.7778/jpkm.2017.31.1.025
  3. 두시 하태독법의 IL-4 활성 조절이 D. farinae 유도 아토피유사피부염 발병 조절에 미치는 효과 vol.31, pp.1, 2015, https://doi.org/10.7778/jpkm.2017.31.1.043
  4. 황련감초 하태독법과 프로바이오틱스의 대장점막 내 면역조절 효과 비교연구 vol.31, pp.2, 2015, https://doi.org/10.7778/jpkm.2017.31.2.048